Packaged Medicaments in   Canada

Overview In November 2024 Canada's Packaged Medicaments exports accounted up to C$638M and imports accounted up to C$1.17B, resulting in a negative trade balance of C$533M. Between November 2023 and November 2024 the exports of Canada's   Packaged Medicaments have decreased by C$-62.6M (-8.93%) from C$701M to C$638M, while imports increased by C$166M (16.5%) from C$1.01B to C$1.17B.

Destinations In November 2024, Packaged Medicaments were exported mostly to United States (C$354M), Japan (C$59.4M), Italy (C$50.8M), China (C$45.4M), and Ireland (C$17.1M), and were imported mostly from United States (C$472M), Ireland (C$90.6M), Germany (C$79.6M), Switzerland (C$74.3M), and Italy (C$56.6M).

Growth In November 2024, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Netherlands (C$-390M or -97.8%), Australia (C$-40.4M or -79.7%), and New Zealand (C$-23.7M or -96.3%). In November 2024, the increase in Packaged Medicaments's year-by-year imports was explained primarily by an increase in imports from Sweden (C$70M or 235%), Denmark (C$54.9M or 122%), and Germany (C$47.3M or 48.3%).